Summit Therapeutics (SMMT) Profit After Tax (2019 - 2026)
Summit Therapeutics (SMMT) posted Profit After Tax of -$92000.0 for Q1 2026, up 99.96% on a QoQ basis from -$219.2 million in Q4 2025, and up 99.85% year-over-year from -$46033.5 in Q1 2025.
Summit Therapeutics (SMMT) Profit After Tax (2019 - 2026) Analysis & Trends
Summit Therapeutics' Profit After Tax history runs 8 years deep, the most recent figure standing at -$92000.0 for Q1 2026.
- Quarterly Profit After Tax rose 99.85% year-over-year to -$92000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$219.4 million (down 76.38% YoY) and the FY2025 annual result came in at -$1.1 billion, down 387.81% from the prior year.
- Profit After Tax was -$92000.0 for Q1 2026 at Summit Therapeutics, up from -$219.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $191000.0 in Q3 2024 and bottomed at -$541.9 million in Q1 2023.
- A 5-year average of -$63.6 million and a median of -$21.2 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax tumbled 2240.02% — and 2024, when it surged 100.9%.
- Summit Therapeutics' Profit After Tax stood at -$19.2 million in 2022, then tumbled by 87.93% to -$36.1 million in 2023, then tumbled by 69.75% to -$61.3 million in 2024, then tumbled by 257.29% to -$219.2 million in 2025, then soared by 99.96% to -$92000.0 in 2026.
- Business Quant data shows SMMT's Profit After Tax at -$92000.0 in Q1 2026, -$219.2 million in Q4 2025, and $43000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | -92,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92,000.00 |
| Dec 31, 2025 | -219.17 Mn |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | -189,000.00 |
| Mar 31, 2025 | -63.19 Mn |
| Dec 31, 2024 | -61.34 Mn |
| Sep 30, 2024 | 191,000.00 |
| Jun 30, 2024 | -50,000.00 |
| Mar 31, 2024 | -43.47 Mn |
| Dec 31, 2023 | -36.14 Mn |
| Sep 30, 2023 | -21.15 Mn |
| Jun 30, 2023 | -15.76 Mn |
| Mar 31, 2023 | -541.88 Mn |
| Dec 31, 2022 | -19.23 Mn |
| Sep 30, 2022 | -21.43 Mn |
| Jun 30, 2022 | -15.98 Mn |
| Mar 31, 2022 | -23.16 Mn |
| Dec 31, 2021 | -27.10 Mn |
| Sep 30, 2021 | -19.60 Mn |
| Jun 30, 2021 | -23.88 Mn |